In the June 23 Federal Register,FDA announced an Emergency Use Authorization ("EUA") for an in vitro diagnostic device ("IVD") used to detect the novel influenza A virus (H7N9), which was detected in China in 2013. The EUA places conditions on use of the authorized IVD and follows an April 19, 2013, determination of significant potential for a public health emergency that, if occurred, would likely pose a threat to national security or the health and security of U.S. citizens living abroad. The authorization is effective as of April 25.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
